A phrase I’m sure we can all relate to, and one that’s got me thinking about the way we make decisions here at Nonlinear – decisions that affect our users and, ultimately, the way they analyse their data. So, how do we ensure we make the right decisions?
Listening to our customers
We regularly conduct surveys for both Progenesis QI and Progenesis QI for proteomics, asking about the top 3 challenges people face while using the software. So far, we’ve had great responses to these and they’ve given us valuable insight into anything we’re missing or just not doing quite right. While we can’t guarantee to implement all the suggestions we receive, every single one of them is reviewed by the development team, and we do our best to ensure we use these suggestions to improve the “Progenesis experience” for all our users. For example, lots of our users asked for more automation which has led us to develop the automation wizard for Progenesis QI for proteomics v2.0.
As well as specifically targeted questionnaires, we’ll happily receive comments and suggestions via emails to our support team. It might be that a request comes in for something Progenesis can already do, in which case we’ll guide you through the process; it might even prompt the writing of a new FAQ or a redesign of the functionality in the software.
The Progenesis Improvement Program
When you opt-in to the Progenesis Improvement Program, the software will collect information about how it’s being used and about any problems you encounter. Back at Nonlinear HQ, we can then use this information to identify which features are used most heavily, which are rarely used, and which parts of the analysis are fast or slow. This helps us to see where we need to improve performance, where we could add a small but helpful feature, where we need better instructions, and much more. If you haven’t opted in already, give it a go – you can always opt out again at any time.
Our Scientific Advisory Board
Our long term decision making is helped by our Scientific Advisory Board. This is a group of prominent scientists who meet once a year and discuss with us what we should be considering long term. These are lively and interesting sessions; the board is candid and tells us if it thinks we are going in the wrong direction or wasting time and resource. An example of this is that we were considering developing a pathway analysis tool but the board said, “Don’t. Better to integrate with what’s already available”. Hence Progenesis QI for proteomics v2.0 now includes direct support for export to third party pathway analysis programs such as IMPaLA and PANTHER.
So if you’ve got an idea on how to make Progenesis even better, or simply want to try the software for yourself, get in touch.